A3P Dublin – 3rd November 2026
TEG is delighted to be attending the inaugural A3P Ireland Congress on Tuesday, 3 November 2026, at the National Institute for Bioprocessing Research and Training (NIBRT) in Dublin.
Bringing together professionals from across the biopharmaceutical industry, the congress will explore key topics shaping pharmaceutical manufacturing and regulatory compliance, including EU GMP Annex 1, sterile processes, Indirect Product Contact Parts, and the evolving regulatory landscape.
TEG Expertise on the Programme
TEG’s Anthony Carey, who is part of the congress organising committee, will be among the key speakers at the event. Joining industry experts from leading pharmaceutical companies, including Pfizer, BMS, Novo Nordisk, Sanofi and Astellas, Anthony will contribute to a programme designed to share practical insights and encourage discussion across the industry.
The event will also feature an exhibition, networking opportunities and a guided tour of NIBRT, providing attendees with opportunities to exchange knowledge, explore industry developments and connect with fellow professionals.
Meet In Person
TEG supports the biopharmaceutical sector with specialist engineering solutions and technical expertise, helping customers address complex manufacturing and compliance challenges. The A3P Ireland Congress offers a valuable opportunity to connect with industry colleagues and discuss the challenges and opportunities shaping the future of biopharmaceutical manufacturing.
Event details
- Date: Tuesday, 3 November 2026
- Time: 08:30–17:00
- Venue: NIBRT, Dublin
- TEG exhibition stand: Booth 3
For the full programme and registration details, visit the A3P Ireland Congress event website.
We look forward to connecting with industry peers in Dublin and contributing to the discussions shaping the future of pharmaceutical manufacturing.
